1.
Barangi VC, Shastri LA, Chowdegowda PK, Sangappanavar R, Inamdar K, Dalbanjan NP, et al. Design and synthesis of new coumarin-1,2,3-triazole hybrids as new antidiabetic agents: In vitro α-amylase, α-glucosidase inhibition, anti-inflammatory, and docking study. Eur. J. Chem. [Internet]. 2024 Sep. 30 [cited 2024 Sep. 30];15(3):205-19. Available from: https://eurjchem.com/index.php/eurjchem/article/view/2541